Seppic acquires naturals active ingredients division from Bayer
Seppic is a subsidiary of Air Liquide, one of the major chemicals companies servicing industry and health companies. The announcement of the acquisition was released by Air Liquide, which noted that the move is intended to “strengthen Seppic’s footprint in natural active ingredients for cosmetics”.
Serdex, the specialist of botanical active ingredients for dermo-cosmetics and skin treatment, with a turnover of €8 million in 2015, the company explains.
Serdex brings to Seppic its expertise in high purity extraction, in sourcing of exotic plants, and notably its knowledge of Malagasy plants, and its 40 employees based in Pau, France.
The move confirms Seppic is keen to demonstrate commitment to the naturals market within cosmetics, as the trend continues to dominate and grow.
Details of the deal
Seppic designs and supplies a wide range of specialty ingredients for health and beauty care, the company states.
Present in over 100 countries through its affiliates and network of distributors, it employs 660 people around the world, including 100 employees dedicated to innovation.
Speaking of the acquisition, François Jackow, member of the Air Liquide group’s Executive Committee, said: “The complementarity of Serdex and Seppic allows us to widen our know-how to better serve our beauty care customers and continue the development of this eco-responsibly sourced active ingredients activity.”
The exec confirmed that the acquisition is intended to strengthen Seppic and Air Liquide’s standing when it comes to naturals.
“With this acquisition, Air Liquide strengthens its position in the market of active ingredients of natural origin, meeting the high and increasing demand of consumers for these ingredients,” he asserted.
